Expert US stock margin analysis and operational efficiency metrics to identify companies with improving profitability. We track key performance indicators that often signal fundamental improvement before it shows up in earnings.
As of April 7, 2026, Collegium Pharmaceutical Inc. (COLL) trades at $32.76, posting a modest 0.52% gain on the day. This analysis examines key technical levels, recent trading context, and potential near-term scenarios for the specialty pharmaceutical firm, which focuses on developing and commercializing prescription pain management therapies. No recent earnings data is available for COLL as of this writing, so market focus has been largely on technical price action and broader sector trends in
What technical signals show for Collegium (COLL) Stock | Price at $32.76, Up 0.52% - Crowd Trend Signals
COLL - Stock Analysis
4295 Comments
1889 Likes
1
Amiryah
Elite Member
2 hours ago
This feels like something is off.
๐ 98
Reply
2
Pearlann
Engaged Reader
5 hours ago
I read this and now I feel different.
๐ 190
Reply
3
Akshitha
Registered User
1 day ago
That skill should be illegal. ๐
๐ 226
Reply
4
Shawnika
New Visitor
1 day ago
Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
๐ 257
Reply
5
Uriah
Engaged Reader
2 days ago
Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment and Wall Street expectations for specific stocks. We aggregate analyst opinions to provide a consensus view of Wall Street expectations including price targets and ratings. We provide consensus ratings, price target analysis, and analyst sentiment for comprehensive coverage. Understand market expectations with our comprehensive analyst coverage and consensus analysis tools for sentiment investing.
๐ 159
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.